Your browser doesn't support javascript.
Efficacy and safety of favipiravir in patients with COVID-19: a review of systematic reviews and metaanalysis
Urmia Medical Journal ; 32(10):782-792, 2022.
Article in English | GIM | ID: covidwho-2012533
ABSTRACT
Background &

Aims:

Favipiravir is an antiviral drug that is widely used in patients with Covid-19. The aim of this study was to review the systematic review and meta-analysis studies of Favipiravir in patients with Covid-19. Materials &

Methods:

An electronic search was conducted in PubMed, Scopus, Cochrane Library, and Web of Science databases until December 2021. In addition, other databases were searched. A manual search of studies and other sources was also conducted to find evidence. The Overview Quality Assessment Questionnaire tool was used to evaluate the quality of articles.
Keywords
Search on Google
Collection: Databases of international organizations Database: GIM Type of study: Reviews / Systematic review/Meta Analysis Language: English Journal: Urmia Medical Journal Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: GIM Type of study: Reviews / Systematic review/Meta Analysis Language: English Journal: Urmia Medical Journal Year: 2022 Document Type: Article